Akso Health Group Valuation

Is 8HX undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 8HX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 8HX (€0.77) is trading below our estimate of fair value (€1.43)

Significantly Below Fair Value: 8HX is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 8HX?

Key metric: As 8HX barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for 8HX. This is calculated by dividing 8HX's market cap by their current book value.
What is 8HX's PB Ratio?
PB Ratio	1x
Book	US$138.37m
Market Cap	US$141.51m

8HX key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	24.2x
Enterprise Value/EBITDA	n/a
PEG Ratio	n/a

Price to Book Ratio vs Peers

How does 8HX's PB Ratio compare to its peers?

The above table shows the PB ratio for 8HX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PB	Estimated Growth	Market Cap
Peer Average	1.7x
ILM1 Medios	0.6x	43.9%	€324.0m
HAEK HAEMATO	0.4x	n/a	€64.3m
MED MEDICLIN	0.6x	63.2%	€121.6m
LIK LIMES Schlosskliniken	5.2x	n/a	€96.2m
8HX Akso Health Group	1x	n/a	€141.5m

Price-To-Book vs Peers: 8HX is good value based on its Price-To-Book Ratio (1x) compared to the peer average (1.7x).

Price to Book Ratio vs Industry

How does 8HX's PB Ratio compare vs other companies in the DE Healthcare Industry?

1 Company	Price / Book	Estimated Growth	Market Cap
HT6 Learning 2 Sleep L2S	0.03x	n/a	US$93.28k

No more companies available in this PB range

1 Company		Estimated Growth	Market Cap

No more companies

Price-To-Book vs Industry: 8HX is good value based on its Price-To-Book Ratio (1x) compared to the European Healthcare industry average (1.6x).

Price to Book Ratio vs Fair Ratio

What is 8HX's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

8HX PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio	1x
Fair PB Ratio	n/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate 8HX's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Shandong Weigao Group Medical Polymer

HK$20.6b

Engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China.

UK2

HK$0.53

1.0%

-34.2%

LNA Santé

€234.2m

Engages in the management and operation of health establishments.

2N3

€22.30

-4.9%

16.8%

Top Glove Corporation Bhd

RM 7.8b

An investment holding company, manufactures, trades in, and sells gloves in Malaysia, Thailand, the People’s Republic of China, and internationally.

5OU

RM 0.98

0.5%

-82.5%